Impact of levothyroxine in miscarriage and preterm delivery rates in first trimester thyroid antibody positive women with TSH less than 2.5 mIU/L

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 10, 2016, Pages 3685-3690

  Negro, Roberto ^a   Schwartz, Alan ^b   Stagnaro Green, Alex ^c  

^a VITO FAZZI HOSPITAL   (Italy)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; AUTOANTIBODY; AUTOANTIGEN; IODIDE PEROXIDASE; IRON BINDING PROTEIN; TPO PROTEIN, HUMAN;

ADULT; ARTICLE; AUTOIMMUNE THYROIDITIS; CONTROLLED STUDY; DRUG EFFICACY; EUTHYROIDISM; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HUMAN; INTERVENTION STUDY; ITALY; MAJOR CLINICAL STUDY; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SPONTANEOUS ABORTION; ABORTION, SPONTANEOUS; ADOLESCENT; BLOOD; IMMUNOLOGY; OUTCOME ASSESSMENT; PREGNANCY; PREMATURE BIRTH; YOUNG ADULT;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; AUTOANTIBODIES; AUTOANTIGENS; FEMALE; HUMANS; IODIDE PEROXIDASE; IRON-BINDING PROTEINS; ITALY; OUTCOME ASSESSMENT (HEALTH CARE); PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREMATURE BIRTH; THYROTROPIN; THYROXINE; YOUNG ADULT;

EID: 84991728471     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2016-1803     Document Type: Article

References (24)

1. Stagnaro-Green A, Pearce E. Thyroid disorders in pregnancy. Nat Rev Endocrinol. 2012;8:650-658.
2. Stagnaro-Green A. Overt hyperthyroidism and hypothyroidism during pregnancy. Clin Obstet Gynecol. 2011;54:478-487.
3. Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002;12:63-68.
4. Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the american thyroid association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21:1081-1125.
5. De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:2543-2565.
6. American College of Obstetricians and Gynecologists. Practice bulletin no. 148: thyroid disease in pregnancy. Obstet Gynecol. 2015; 125:996-1005.
7. Casey BM, Dashe JS, Wells CE, McIntire DD, Leveno KJ, Cunning-hamFG.Subclinical hyperthyroidism and pregnancy outcomes.Ob-stet Gynecol. 2006;107:337-341.
8. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999;341:549-555.
9. Allan WC, Haddow JE, Palomaki GE, et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen. 2000;7:127-130.
10. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab. 2010;95:E44-E48.
11. Casey BM, Dashe JS, Wells CE, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol. 2005;105:239-245.
12. Maraka S, Singh Ospina NM, O'Keeffe DT, et al. Subclinical hy-pothyroidism in pregnancy: a systematic review and meta-analysis. Thyroid. 2016;26:580-590.
13. Lazarus JH, Bestwick JP, Channon S, et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med. 2012;366: 493-501.
14. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Universal screening versus case finding for detection and treatmentofthyroid hormonal dysfunction during pregnancy.J Clin Endocrinol Metab. 2010;95:1699-1707.
15. Stagnaro-Green A, Roman SH, Cobin RH, el-Harazy E, Alvarez-Marfany M, Davies TF. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA. 1990; 264:1422-1425.
16. Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J, Cooma-rasamy A. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ. 2011;342: d2616.
17. Stagnaro-Green A. Thyroid antibodies and miscarriage: where are we at a generation later? J Thyroid Res. 2011;2011:841949.
18. Toulis KA, Goulis DG, Venetis CA, et al. Risk of spontaneous miscarriage in euthyroid women with thyroid autoimmunity undergoing IVF: a meta-analysis. Eur J Endocrinol. 2010;162:643-652.
19. Abbassi-Ghanavati M, Casey BM, Spong CY, McIntire DD, Hal-vorson LM, Cunningham FG. Pregnancy outcomes in women with thyroid peroxidase antibodies. Obstet Gynecol. 2010;116:381-386.
20. Haddow JE, McClain MR, Palomaki GE, et al. Thyroperoxidase and thyroglobulin antibodies in early pregnancy and placental abruption. Obstet Gynecol. 2011;117:287-292.
21. Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab. 2006;91:2587-2591.
22. Plowden TC, Schisterman EF, Sjaarda LA, et al. Subclinical hypo-thyroidism and thyroid autoimmunity are not associated with fecundity, pregnancy loss, or live birth. J Clin Endocrinol Metab. 2016;101:2358-2365.
23. Unuane D, Velkeniers B, Anckaert E, et al. Thyroglobulin autoan-tibodies: is there any added value in the detection of thyroid auto-immunity in women consulting for fertility treatment? Thyroid. 2013;23:1022-1028.
24. Vissenberg R, van Dijk MM, Fliers E, et al. Effect of levothyroxine on live birth rateineuthyroid women with recurrent miscarriage and TPO antibodies (T4-LIFE study). Contemp Clin Trials. 2015; S1551-714430061-6.